6.
MASUMURA Y, Kobayashi A, Yamazaki N
. Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure. Jpn Circ J. 1990; 54(12):1471-6.
DOI: 10.1253/jcj.54.12_1471.
View
7.
Nishikimi T, Akimoto K, Wang X, Mori Y, Tadokoro K, Ishikawa Y
. Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats. J Hypertens. 2004; 22(9):1787-96.
DOI: 10.1097/00004872-200409000-00024.
View
8.
Schonekess B, Allard M, Lopaschuk G
. Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ Res. 1995; 77(4):726-34.
DOI: 10.1161/01.res.77.4.726.
View
9.
Rodriguez A, Mousa A, Ebeling P, Scott D, de Courten B
. Effects of vitamin D supplementation on inflammatory markers in heart failure: a systematic review and meta-analysis of randomized controlled trials. Sci Rep. 2018; 8(1):1169.
PMC: 5773527.
DOI: 10.1038/s41598-018-19708-0.
View
10.
van der Meij B, Langius J, Smit E, Spreeuwenberg M, von Blomberg B, Heijboer A
. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr. 2010; 140(10):1774-80.
DOI: 10.3945/jn.110.121202.
View
11.
Farkas J, von Haehling S, Kalantar-Zadeh K, Morley J, Anker S, Lainscak M
. Cachexia as a major public health problem: frequent, costly, and deadly. J Cachexia Sarcopenia Muscle. 2013; 4(3):173-8.
PMC: 3774921.
DOI: 10.1007/s13539-013-0105-y.
View
12.
Cheung W, Hao S, Wang Z, Ding W, Zheng R, Gonzalez A
. Vitamin D repletion ameliorates adipose tissue browning and muscle wasting in infantile nephropathic cystinosis-associated cachexia. J Cachexia Sarcopenia Muscle. 2019; 11(1):120-134.
PMC: 7015252.
DOI: 10.1002/jcsm.12497.
View
13.
Deluca H
. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004; 80(6 Suppl):1689S-96S.
DOI: 10.1093/ajcn/80.6.1689S.
View
14.
Kannel W, Belanger A
. Epidemiology of heart failure. Am Heart J. 1991; 121(3 Pt 1):951-7.
DOI: 10.1016/0002-8703(91)90225-7.
View
15.
Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Kawamoto A
. Analysis of liver metabolism in a rat model of heart failure. Int J Cardiol. 2011; 161(3):130-6.
DOI: 10.1016/j.ijcard.2011.07.056.
View
16.
Anker S, Chua T, Ponikowski P, Harrington D, Swan J, Kox W
. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997; 96(2):526-34.
DOI: 10.1161/01.cir.96.2.526.
View
17.
Muscaritoli M, Anker S, Argiles J, Aversa Z, Bauer J, Biolo G
. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010; 29(2):154-9.
DOI: 10.1016/j.clnu.2009.12.004.
View
18.
Fearon K, Von Meyenfeldt M, Moses A, Van Geenen R, Roy A, Gouma D
. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003; 52(10):1479-86.
PMC: 1773823.
DOI: 10.1136/gut.52.10.1479.
View
19.
Schierbeck L, Jensen T, Bang U, Jensen G, Kober L, Jensen J
. Parathyroid hormone and vitamin D--markers for cardiovascular and all cause mortality in heart failure. Eur J Heart Fail. 2011; 13(6):626-32.
DOI: 10.1093/eurjhf/hfr016.
View
20.
Serati A, Motamedi M, Emami S, Varedi P, Movahed M
. L-carnitine treatment in patients with mild diastolic heart failure is associated with improvement in diastolic function and symptoms. Cardiology. 2010; 116(3):178-82.
DOI: 10.1159/000318810.
View